Adam Brenner > DLA Piper LLP (US) > New York, United States > Lawyer Profile
DLA Piper LLP (US) Offices
1251 6TH AVE,
NEW YORK, NY 10020-1104
NEW YORK
United States
- Firm Profile
- Go to...
Adam Brenner
Work Department
Corporate; Private Equity
Position
Partner
Career
Adam Brenner focuses on representing innovative, institutionally backed companies, with extensive experience in equity and debt financings, mergers and acquisitions and general corporate governance. He also represents venture capital funds in their deployment of capital. While Adam represents companies in a variety of industry verticals, he has particular experience advising emerging companies with international operations on regulatory matters relating to national security and in international trade. Adam is also a co-founder of the non-profit Accelerate Yale, a global community of alumni and friends of Yale who are engaged in innovation, tech and entrepreneurship.
Education
J.D., Boston College Law School; M. Ed., Boston College; B.A., Yale University
Top Tier Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Tax > International tax
- Real estate > Land use/zoning
- Investment fund formation and management > Alternative/hedge funds
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate
- Government > State attorneys general
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
Firm Rankings
- Media, technology and telecoms > Advertising and marketing: transactional and regulatory
- Industry focus > Cannabis
- Antitrust > Cartel
- Dispute resolution > E-discovery
- Tax > Financial products
- Finance > Fintech
- Intellectual property > Patents: litigation (full coverage)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Structured finance: securitization
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Tax > US taxes: contentious
- M&A/corporate and commercial > Venture capital and emerging companies
- Labor and employment > Workplace and employment counseling
- Insurance > Advice to insurers
- Intellectual property > Copyright
- Environment > Environment: regulatory
- Insurance > Insurance: non-contentious
- Labor and employment > Labor and employment disputes (including collective actions)
- Labor and employment > Labor-management relations
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
- Finance > Capital markets: equity offerings
- Antitrust > Civil litigation/class actions: defense
- Real estate > Construction (including construction litigation)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: litigation
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Dispute resolution > International arbitration
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Healthcare > Service providers
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Finance > Project finance
- Dispute resolution > Corporate investigations and white-collar criminal defense